AstraZeneca brushes aside “Incorrect” reports on its Covid jab efficacy

Berlin, Germany: AstraZeneca has rejected baseless reports on the efficacy of its Covid vaccine on elderly persons.

The pharma has vociferously defended the efficacy of its coronavirus vaccine after media reports said the German government had reservations over the effectiveness of the vaccine among those over 65.

The firm in its statement said that reports that the AstraZeneca/Oxford vaccine efficacy is as low as 8% in adults over 65 years are completely incorrect.

The European Union issued an angry warning to AstraZeneca Monday over its unexpected delay in delivering millions of doses of its Covid-19 vaccine to the bloc.

The pharma giant had earlier said it would not meet its contractual delivery commitments to the European Union because of unexplained “reduced yields” in its European supply chain.